Hennion & Walsh Asset Management »

Miragen Therapeutics shares owned by Hennion & Walsh Asset Management

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Hennion & Walsh Asset Management from 13F filings

Historical chart of Hennion & Walsh Asset Management investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Hennion & Walsh Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Hennion & Walsh Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.5M 197k 22.75
2024-06-30 $2.3M 179k 13.01
2024-03-31 $1.9M 110k 17.51
2023-12-31 $1.7M 76k 21.78
2023-09-30 $416k 27k 15.34
2023-06-30 $340k 14k 23.77

More positions owned by Hennion & Walsh Asset Management

Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Wisdomtree Tr Intl Qulty Div (IQDG)
J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)
Ishares Tr Investment Grade (IGEB)
Proshares Tr S&p 500 High Inc (ISPY)
Ishares Tr Core S&p500 Etf (IVV)
Goldman Sachs Etf Tr Activebeta Int (GSIE)
Wisdomtree Tr Us S Cap Qty Div (DGRS)
Global X Fds Us Pfd Etf (PFFD)
Nuveen Div. Advantage Muni. Fund (NAD)
Nuveen Insured Tax-Free Adv Munici (NEA)
Columbia Etf Tr Ii Em Core Ex Etf (XCEM)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
NVIDIA Corporation (NVDA)
Apple (AAPL)

View all positions for Hennion & Walsh Asset Management

Top funds holding Miragen Therapeutics

BlackRock
BlackRock
Deep Track Capital
VR Adviser
Fairmount Funds Management
Vanguard Group
Paradigm Biocapital Advisors
Perceptive Advisors
State Street Corporation
Commodore Capital
Novo A/S
Tang Capital Management
Alliancebernstein
Maverick Capital
Driehaus Capital Management

View all funds holding Miragen Therapeutics